|
There's Now a $1-a-Pill Competitor to Pharma CEO Martin Shkreli's $750-a-Pill DrugBusiness InsiderOct. 23, 2015 |
Popular 
IDF Soldier Takes Sledgehammer to Jesus Statue During Operations in Lebanon
Mark Levin and Jonathan Pollard Push for Nuking Iran
Trump Says U.S. Sent 'A Lot of Guns' to Iranian 'Protesters'
Reuters: Trump Approved Iran Strikes After Speaking With Netanyahu
Carrie Prejean Boller Takes on the Zionist Lobby at White House Religious Liberty Commission
 Almost a month after word got out that drug-company CEO Martin Shkreli had jacked up the price of a critical drug by more than 5,000%, a different kind of pharma company has stepped up to provide a cheaper alternative. Read More 
|
